LILLY FDA Approval ANDA 060385

ANDA 060385

LILLY

FDA Drug Application

Application #060385

Application Sponsors

ANDA 060385LILLY

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL500MG0NEOMYCIN SULFATENEOMYCIN SULFATE

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 60385
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.